US Regulatory Update: MoCRA and Beyond
In the morning session, Craig Weiss will provide an up‑to‑date overview of the US FDA’s progress in meeting the requirements established under MoCRA. He will briefly recap the core elements of the law and outline the reports, guidance documents, and implementation steps the FDA has released to date. Craig will also examine emerging state‑level regulations—particularly those introducing new chemical limits and ingredient bans—and highlight the areas posing the greatest challenges for industry compliance.
In the afternoon session Teena Warrin will provide an update on the latest CEPA publications and outline what’s expected in upcoming releases. She will also review recent and proposed changes to the Hot List, highlighting key amendments and their implications for ingredient use and compliance.
FREE for Members in person ($60.00 virtual)
Non-Members ($125.00 in person or virtual)
FREE for Students in person ($60.00 virtual)
Register here